1.3000
09-5月-25 15:45:00
15 分の遅延
株式
-0.1700
-11.56%
本日の幅
1.3000 - 1.5500
ISIN
N/A
ソース
NASDAQ
HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
30 1 2025 06:00:00 提供 Nasdaq GlobeNewswire